Literature DB >> 19037712

The beta1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Galphas.

Junfang Zheng1, Hui Shen, Ying Xiong, Xiaomei Yang, Junqi He.   

Abstract

beta-Adrenergic receptors can activate extracellular signal-regulated kinases (ERKs) via different mechanisms. In this study, we investigated the molecular mechanism of beta1-adrenergic receptor (beta1AR)-mediated ERK activation in African green monkey kidney COS-7 cells. Treatment of cells with isoproterenol (ISO), a beta1AR selective agonist, induced phosphorylation of ERK1/2 in a dose-dependent manner. ISO-stimulated ERK phosphorylation was not influenced by the Gbetagamma inhibitor, betaAR kinase carboxyl terminal (betaARKct) or by the Gi inhibitor, pertussis toxin (PTX), but it was clearly abolished via inhibition of protein kinase A (PKA) with H89, or of mitogen-activated protein kinase kinase (MEK1) with PD98059, revealing that the Galphas subunit is involved in ERK regulation through the PKA/MEK1 pathway. We also tested the effect of the adenylate cyclase activator forskolin on ERK activation, and the result was identical to that of ISO stimulation. Moreover, pretreatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 or with the Src tyrosine kinase inhibitor PP2 did not affect ERK activation. These observations suggest a mechanism of beta1AR-mediated ERK activity that involves the Galphas subunit, but not EGFR or Src tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037712     DOI: 10.1007/s00726-008-0207-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

1.  The basolateral amygdala regulates adaptation to stress via β-adrenergic receptor-mediated reductions in phosphorylated extracellular signal-regulated kinase.

Authors:  N M Grissom; S Bhatnagar
Journal:  Neuroscience       Date:  2011-01-20       Impact factor: 3.590

2.  PAR2-Mediated cAMP Generation Suppresses TRPV4-Dependent Ca2+ Signaling in Alveolar Macrophages to Resolve TLR4-Induced Inflammation.

Authors:  Sheikh Rayees; Jagdish Chandra Joshi; Mohammad Tauseef; Mumtaz Anwar; Sukriti Baweja; Ian Rochford; Bhagwati Joshi; Morley D Hollenberg; Sekhar P Reddy; Dolly Mehta
Journal:  Cell Rep       Date:  2019-04-16       Impact factor: 9.423

3.  Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium.

Authors:  Louise E See Hoe; Jan M Schilling; Anna R Busija; Kristofer J Haushalter; Victoria Ozberk; Malik M Keshwani; David M Roth; Eugene Du Toit; John P Headrick; Hemal H Patel; Jason N Peart
Journal:  Eur J Pharmacol       Date:  2016-06-30       Impact factor: 4.432

4.  EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Authors:  Wenfang Yao; Duiping Feng; Weihua Bian; Longyan Yang; Yang Li; Zhiyu Yang; Ying Xiong; Junfang Zheng; Renyou Zhai; Junqi He
Journal:  Amino Acids       Date:  2012-04-04       Impact factor: 3.520

5.  N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and -independent mechanisms.

Authors:  Yanmei Zhang; Gaoyong Chen; Shuping Zhong; Fuchun Zheng; Fenfei Gao; Yicun Chen; Zhanqin Huang; Wenfeng Cai; Weiqiu Li; Xingping Liu; Yanshan Zheng; Han Xu; Ganggang Shi
Journal:  Oxid Med Cell Longev       Date:  2013-11-12       Impact factor: 6.543

6.  Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.

Authors:  Junfang Zheng; Lei Wang; Zhiqiang Peng; Ying Yang; Duiping Feng; Junqi He
Journal:  EBioMedicine       Date:  2016-12-09       Impact factor: 8.143

Review 7.  The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Authors:  Tomasz Boczek; Joanna Mackiewicz; Marta Sobolczyk; Julia Wawrzyniak; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.